Microbix Biosystems Inc.
MBXBF
$0.17
$0.0021.19%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.15M | 16.34M | 16.81M | 18.67M | 17.23M |
| Total Other Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Revenue | 15.15M | 16.34M | 16.81M | 18.67M | 17.23M |
| Cost of Revenue | 6.71M | 6.91M | 7.39M | 7.35M | 7.39M |
| Gross Profit | 8.44M | 9.43M | 9.42M | 11.32M | 9.85M |
| SG&A Expenses | 6.43M | 6.37M | 6.14M | 6.91M | 6.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.77M | 14.91M | 15.16M | 15.83M | 15.65M |
| Operating Income | 377.60K | 1.43M | 1.65M | 2.84M | 1.58M |
| Income Before Tax | -127.50K | 1.24M | 1.51M | 2.70M | 3.75M |
| Income Tax Expenses | 110.40K | 110.40K | 110.40K | 110.40K | -- |
| Earnings from Continuing Operations | -0.24 | 1.13 | 1.40 | 2.59 | 3.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -237.90K | 1.13M | 1.40M | 2.59M | 3.75M |
| EBIT | 377.60K | 1.43M | 1.65M | 2.84M | 1.58M |
| EBITDA | 1.49M | 2.53M | 2.75M | 3.97M | 2.57M |
| EPS Basic | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 551.65M | 547.91M | 545.44M | 546.93M | 547.64M |
| Average Diluted Shares Outstanding | 553.83M | 550.85M | 549.35M | 550.21M | 550.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |